D
Donald Klippenstein
Researcher at University of South Florida
Publications - 4
Citations - 707
Donald Klippenstein is an academic researcher from University of South Florida. The author has contributed to research in topics: Lung cancer & Lung cancer screening. The author has an hindex of 4, co-authored 4 publications receiving 538 citations. Previous affiliations of Donald Klippenstein include Moffitt Cancer Center.
Papers
More filters
Journal ArticleDOI
Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
Douglas E. Wood,Ella A. Kazerooni,Scott Baum,Georgie A. Eapen,David S. Ettinger,Lifang Hou,David M. Jackman,Donald Klippenstein,Rohit Kumar,Rudy P. Lackner,Lorriana E. Leard,Inga T. Lennes,Ann N. Leung,Samir S. Makani,Pierre P. Massion,Peter J. Mazzone,Robert E. Merritt,Bryan F. Meyers,David E. Midthun,Sudhakar Pipavath,Christie Pratt,Chakravarthy Reddy,Mary E. Reid,Arnold J. Rotter,Peter B. Sachs,Matthew B. Schabath,Mark L. Schiebler,Betty C. Tong,William D. Travis,Benjamin Wei,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +32 more
TL;DR: This manuscript focuses on identifying patients at high risk for lung cancer who are candidates for low-dose computed tomography of the chest and on evaluating initial screening findings.
Journal ArticleDOI
Lung cancer screening: Clinical practice guidelines in oncology
Douglas E. Wood,George A. Eapen,David S. Ettinger,Lifang Hou,David M. Jackman,Ella A. Kazerooni,Donald Klippenstein,Rudy P. Lackner,Lorriana E. Leard,Ann N. Leung,Pierre P. Massion,Bryan F. Meyers,Reginald F. Munden,Gregory A. Otterson,Kimberly S. Peairs,Sudhakar Pipavath,Christie Pratt-Pozo,Chakravarthy Reddy,Mary E. Reid,Arnold J. Rotter,Matthew B. Schabath,Lecia V. Sequist,Betty C. Tong,William D. Travis,Michael Unger,Stephen C. Yang +25 more
TL;DR: A focus on multidisciplinary programs (incorporating primary care doctors, pulmonologists, radiologists, thoracic surgeons, medical oncologists, and pathologists) will be helpful to optimize decision-making and minimize interventions for patients with benign lung disease.
Journal ArticleDOI
Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines.
Douglas E. Wood,Ella A. Kazerooni,Scott Baum,Mark T. Dransfield,Georgie A. Eapen,David S. Ettinger,Lifang Hou,David M. Jackman,Donald Klippenstein,Rohit Kumar,Rudy P. Lackner,Lorriana E. Leard,Ann N. Leung,Samir S. Makani,Pierre P. Massion,Bryan F. Meyers,Gregory A. Otterson,Kimberly S. Peairs,Sudhakar Pipavath,Christie Pratt-Pozo,Chakravarthy Reddy,Mary E. Reid,Arnold J. Rotter,Peter B. Sachs,Matthew B. Schabath,Lecia V. Sequist,Betty C. Tong,William D. Travis,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +30 more
TL;DR: The major updates to the 2015 NCCN Guidelines for Lung Cancer Screening include a revision to the recommendation from category 2B to 2A for one of the high-risk groups eligible for lung cancer screening.
Journal ArticleDOI
Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival
Hua Wang,Matthew B. Schabath,Ying Liu,Anders Berglund,Gregory C. Bloom,Jongphil Kim,Olya Stringfield,Edward A. Eikman,Donald Klippenstein,John J. Heine,Steven A. Eschrich,Zhaoxiang Ye,Robert J. Gillies +12 more
TL;DR: A subset of the semiquantitative characteristics described herein has prognostic importance and provides the ability to distinguish between different histological subtypes of lung adenocarcinoma.